Sheets Smith Wealth Management
- SEC CIK
- 0001157436
- Latest filing
- Jul 13, 2026
RNAZ holding history
Transcode Therapeutics, Inc. in every 13F filed by Sheets Smith Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNAZ overviewAll 13F holders of RNAZFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −50,138−100.0% | Sold out | Holders |
| Q3 2024 | 50,138 | $28.6K | <0.1% | +30,000+149.0% | Added | Holders |
| Q2 2024 | 20,138 | $20.2K | <0.1% | +20,138 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −60,000−100.0% | Sold out | Holders |
| Q1 2023 | 60,000 | $20.3K | <0.1% | +35,000+140.0% | Added | Holders |
| Q4 2022 | 25,000 | $16.8K | <0.1% | +25,000 | New | Holders |